Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy

HIGHLIGHTS:   What are the main findings? Replacement of VPA with new ASMs provided the same or better seizure control. Replacement of VPA with new ASMs provided better myoclonus control. Subsets of the monotherapy group achieved better seizure control with new ASMs. What is the implication of the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Ayataka, Enoki, Hideo, Hatano, Keisuke, Sato, Keishiro, Okanishi, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369717/
https://www.ncbi.nlm.nih.gov/pubmed/35956197
http://dx.doi.org/10.3390/jcm11154582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369717/
https://www.ncbi.nlm.nih.gov/pubmed/35956197
http://dx.doi.org/10.3390/jcm11154582

Ejemplares similares